Neuroimmune Activation and Neuroinflammation in Chronic Pain and Opioid Tolerance/Hyperalgesia

Neuroscientist

Volumn 10, Issue 1, 2004, Pages 40-52

  DeLeo, Joyce A ^a   Tanga, Flobert Y ^a   Tawfik, Vivianne L ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Astrocyte; Chemokines; Cytokines; Glia; MHC II; Microglia; Neuropathic pain; Toll like receptor 4

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE ANTIGEN; OPIATE; TOLL LIKE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ASTROCYTE; AUTOIMMUNITY; CELL ACTIVATION; CHRONIC PAIN; CYTOKINE PRODUCTION; DRUG TOLERANCE; HYPERALGESIA; INFLAMMATION; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ANALGESICS, OPIOID; ANIMALS; CHRONIC DISEASE; CYTOKINES; DRUG TOLERANCE; HUMANS; HYPERALGESIA; INFLAMMATION; NEUROIMMUNOMODULATION; PAIN;

EID: 1642579573     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/1073858403259950     Document Type: Review

References (64)

1. Abbadie C, Lindia JA, Cumiskey AM, Peterson LB, Mudgett JS, Bayne EK, and others. 2003. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci U S A 100:7947-52.
2. Anderson KV. 2000. Toll signaling pathways in the innate immune response. Curr Opin Immunol 12(1):13-9.
3. Arruda JL, Colbum RW, Rickman AJ, Rutkowski MD, DeLeo JA. 1998. Increase of interleukin-6 mRNA in the spinal cord following peripheral nerve injury in the rat: potential role of IL-6 in neuropathic pain. Mol Br Res 62:228-35.
4. Arruda JL, Sweitzer S, Rutkowski MD, DeLeo JA. 2000. Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: possible immune modulation in neuropathic pain. Br Res 879:216-25.
5. Asenio VC, Campbell IL. 1999. Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci 22:504-12.
6. Bacon KB, Harrison JK. 2000. Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasis. J Neuroimmunol 104:92-7.
7. Böttcher T, von Mering M, Ebert S, Meyding-Lamade U, Kuhnt U, Gerber J, and others. 2003. Differential regulation of Toll-like receptor mRNAs in experimental murine central nervous system infections. Neurosci Lett 344(1):17-20.
8. Chao CC, Hu S, Ehrlich L, Peterson PK. 1995. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immunol 9:355-65.
9. Christensen D, Kayser V. 2000. The development of pain-related behaviour and opioid tolerance after neuropathy-inducing surgery and sham surgery. Pain 88:231-8.
10. Christie MJ, William JT, North RA. 1987. Cellular mechanisms of opioid tolerance: studies in single brain neurons. Mol Pharmacol 32:633-8.
11. Coyle DE. 1998. Partial peripheral nerve injury leads to activation of astroglia and microglia which parallel the development of allodynic behavior. Glia 23(1):75-83.
12. DeLeo JA, Colburn RW, Nichols M, Malhotra A. 1996. Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J Interferon Cytokine Res 16:695-700.
13. DeLeo JA, Rutkowski MD, Stalder AK, Campbell IL. 2000. Transgenic expression of TNF by astrocytes increases mechanical allodynia in a mouse neuropathy model. Neuroreport 11:599-602.
14. DeLeo JA, Winkelstein BA, Rutkowski MD. 2002. The modulatory role of spinal chemokine activation in neuropathic pain. Society for Neuroscience abstract.
15. DeLeo JA, Yezierski RP. 2001. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90:1-6.
16. Eriksson NP, Persson JKE, Aldskogius H, Svensson M. 1997. A quantitative analysis of the glial cell reaction in primary sensory termination areas following sciatic nerve injury and treatment with nerve growth factor in the adult rat. Exp Brain Res 114:393-404.
17. Fu KY, Light AR, Matsushima GK, Maixner W. 1999. Microglial reactions after subcutaneous formalin injection into the rat hind paw. Brain Res 825(1-2):59-67.
18. Garrison CJ, Dougherty PM, Carlton SM. 1994. GFAP expression in lumbar spinal cord of naïve and neuropathic rats treated with MK-801. Exp Neurol 129:237-43.
19. Grzybicki D, Moore SA, Schelper R, Glabinski AR, Ransohoff RM, Murphy S. 1998. Expression of monocyte chemoattractant protein (MCP-1) and nitric oxide synthase-2 following cerebral trauma. Acta Neuropathol 95:98-103.
20. Gul H, Yildiz O, Dogrul A, Yesilyurt O, Isimer A. 2000. The interaction between IL-1β and morphine: possible mechanism of deficiency of morphine-induced analgesia in diabetic mice. Pain 89:39-45.
21. Guntinas-Lichius O, Martinez-Portillo F, Lebeck J, Angelov DN, Stennert E, Neiss WF. 1997. Nimodipine maintains in vivo the increase in GFAP and enhances the astroglial ensheathment of surviving motoneurons in the rat following permanent target deprivation. J Neurocytol 26:241-8.
22. Harstall C, Ospina M. 2003. How prevalent is chronic pain? Pain Clin Updates 11:2.
23. Hashizume H, DeLeo JA, Colburn RW, Weinstein JN. 2000. Spinal glial activation and cytokine expression after lumbar root injury in the rat. Spine 25:1206-17.
24. Hashizume H, Rutkowski MD, Weinstein JN, DeLeo JA. 2000. Central administration of methotrexate reduces mechanical allodynia in an animal model of radiculopathy/sciatica. Pain 87(2):159-69.
25. Hickey WF, Kimura H. 1988. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239:290-2.
26. Homma Y, Brull SJ, Zhang JM. 2002. A comparison of chronic pain behavior following local application of tumor necrosis factor a to the normal and mechanically compressed lumbar ganglia in the rat. Pain 95:239-46.
27. Hughes PM, Botham MS, Frentzel S, Mir A, Perry VH. 2002. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia 37:314-27.
28. Inoue A, Ikoma K, Morioka N, Kumagai K, Hashimoto T, Hide I, and others. 1999. Interleukin-1 beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 system. J Neurochem 73:2206-13.
29. Kreutzberg G. 1996. Microglia: a sensor of pathological events in the CNS. Trends Neurosci 19:312-18.
30. Laflamme N, Rivest S. 2001. Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J 15:155-63.
31. Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, and others. 2002. The Toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 22(7):2478-86.
32. Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA. 2003. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A 100(14):8514-19.
33. Mao J, Sung B, Ji R-R, Lim G. 2002. Chronic morphine induces down-regulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity. J Neurosci 22(18):8312-23.
34. Mayer DJ, Mao J, Holt J, Price DD. 1999. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci U S A 96:7731-6.
35. McTigue DM, Tani M, Krivacic K, Chemosky A, Kelner GS, Maciejewski D, and others. 1998. Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury. J Neurosci Res 53:368-76.
36. Meller ST, Dykastra C, Grzybycki D, Murphy S, Gebhart GF. 1994. The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacol 33:1471-8.
37. Obreja O, Schmelz M, Poole S, Kress M. 2002. Interleukin-6 in combination with its soluble IL-6 receptor sensitizes rat skin nociceptors to heat, in vivo. Pain 96:57-62.
38. Onda A, Hamba M, Yabuki S, Kikuchi S. 2002. Exogenous tumor necrosis factor-alpha induces abnormal discharges in rat dorsal horn neurons. Spine 27:1618-24.
39. Pereira CF, Middel J, Jansen G, Verhoef J, Nottet HS. 2001. Enhanced expression of fractalkine in HIV-1 associated dementia. J Neuroimmunol 115:168-75.
40. Raghavendra V, Rutkowski MD, DeLeo JA. 2002. The role of neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci 22(22):9980-9.
41. Raghavendra V, Tanga F, DeLeo JA. 2003a. Attenuation of morphine tolerance, withdrawal-induced hyperalgesia and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacology.
42. Raghavendra V, Tanga F, DeLeo JA. 2003b. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 306(2): 624-30.
43. Raghavendra V, Tanga F, Rutkowski MD, DeLeo JA. 2003c. Antihyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines. Pain 104:657-65.
44. Ridet JL, Malhotra SK, Privat A, Gage FH. 1997. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 20:570-7.
45. Rivest S. 2003. Molecular insights on the cerebral innate immune system. Brain Behav Immun 17(1):13-9.
46. Rutkowski MD, Winkelstein BA, Hickey WF, Pahl JL, DeLeo JA. 2002. Lumbar nerve root injury induces central nervous system neuroimmune activation and neuroinflammation in the rat: relationship to painful radiculopathy. Spine 27:1604-13.
47. Schafers M, Sorkin LS, Geis C, Shubayev VI. 2003. Spinal nerve ligation induces transient upregulation of tumor necrosis factor receptors 1 and 2 in injured and adjacent uninjured dorsal root ganglion in the rat. Neurosci Lett 347:179-82.
48. Schwartz M, Moalem G, Leibowitz-Amit R, Cohen IR. 1999. Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci 22:295-9.
49. Serou MJ, DeCoster MA, Bazan NG. 1999. Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression. J Neurosci Res 58:593-8.
50. Song P, Zhao Z-Q. 2001. The involvement of glial cells in the development of morphine tolerance. Neurosci Res 39:281-6.
51. Streit WJ, Greaber MB, Kreutzberg GW. 1989. Expression of Ia antigen on perivascular and microglial cells after sublethal and lethal motor neuron injury. Exp Neurol 105(2):115-26.
52. Sweitzer SM, Hickey WF, DeLeo JA. 2002a. Focal nerve injury induces leukocyte trafficking into the CNS: Relationship to neuropathic pain. Pain 100:163-70.
53. Sweitzer SM, Martin D, DeLeo JA. 2001. Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 103:529-39.
54. Sweitzer SM, Schubert P, DeLeo JA. 2001. Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. J Pharmacol Exp Ther 297:1210-17.
55. Sweitzer SM, White KA, Dutta C, DeLeo JA. 2002b. The differential role of spinal MHC class II and cellular adhesion molecules in peripheral inflammatory versus neuropathic pain in rodents. J Neuroimmunol 125:82-93.
56. Tanga FY, Raghavendra V, DeLeo JA. 2003 (in press). Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain.
57. Tarozzo G, Campanella M, Ghiani M, Bulfone A, Beltramo M. 2002. Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia-reperfusion brain injury in the rat. Eur J Neurosci 15:1663-8.
58. Trujillo KA, Akil H. 1991. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251:85-7.
59. Vass K, Lassmann H. 1990. Intrathecal application of interferon gamma. Progressive appearance of MHC antigens within the rat nervous system. Am J Pathol 137:789-800.
60. Watkins LR, Maier SF, Goehler LE. 1995. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63:289-302.
61. Winkelstein BA, Rutkowski MD, Sweitzer SM, Pahl JL, DeLeo JA. 2001. Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment. J Comp Neurol 439:127-39.
62. Wright SD. 1999. Toll, a new piece in the puzzle of innate immunity. J Exp Med 189:13-9.
63. Wyss-Coray T, Mucke L. 2000. Inflammation in neurodegenerative disease-a double-edge sword. Neuron 35:419-32.
64. Zhang JM, Li H, Liu B, Brull SJ. 2002. Acute topical application of tumor necrosis factor alpha evokes protein kinase A-dependent responses in rat sensory neurons. J Neurophysiol 88:1387-92.